Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2006 1
2008 4
2009 2
2010 2
2011 2
2012 5
2013 2
2014 5
2015 2
2016 1
2017 2
2018 1
2019 2
2020 1
2021 1
2023 2
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K; PHOENIX 2 study investigators. Papp KA, et al. Lancet. 2008 May 17;371(9625):1675-84. doi: 10.1016/S0140-6736(08)60726-6. Lancet. 2008. PMID: 18486740 Clinical Trial.
A Patient Charter for Chronic Urticaria.
Maurer M, Albuquerque M, Boursiquot JN, Dery E, Giménez-Arnau A, Godse K, Guitiérrez G, Kanani A, Lacuesta G, McCarthy J, Nigen S, Winders T. Maurer M, et al. Among authors: nigen s. Adv Ther. 2024 Jan;41(1):14-33. doi: 10.1007/s12325-023-02724-6. Epub 2023 Nov 22. Adv Ther. 2024. PMID: 37991694 Free PMC article.
Inhibition of IL-13: A New Pathway for Atopic Dermatitis.
Ratnarajah K, Le M, Muntyanu A, Mathieu S, Nigen S, Litvinov IV, Jack CS, Netchiporouk E. Ratnarajah K, et al. Among authors: nigen s. J Cutan Med Surg. 2021 May-Jun;25(3):315-328. doi: 10.1177/1203475420982553. Epub 2020 Dec 22. J Cutan Med Surg. 2021. PMID: 33350863 Review.
Etanercept in the treatment of palmoplantar pustulosis.
Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S. Bissonnette R, et al. Among authors: nigen s. J Drugs Dermatol. 2008 Oct;7(10):940-6. J Drugs Dermatol. 2008. PMID: 19112757 Clinical Trial.
31 results